Disease Info Card

Steroid Sulfatase Deficiency Disease

Information about Steroid Sulfatase Deficiency Disease: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Steroid Sulfatase Deficiency Disease

Most recent studies have shown that Steroid Sulfatase Deficiency Disease shares some biological mechanisms with carcinoma, deficiency-of-sulfatase, histiocytoma-benign-fibrous, ichthyoses, ichthyosis-x-linked, infective-disorder, infertility, leiomyosarcoma, liposarcoma, malignant-neoplasm-of-breast, malignant-neoplasms, malignant-paraganglionic-neoplasm, mammary-neoplasms, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, pneumonia, rhabdomyosarcoma, sarcoma, soft-tissue-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Steroid Sulfatase Deficiency Disease, and have been seen in publications frequently: Angiogenesis, Cell Cycle, Cell Death, Cell Growth, Cell Proliferation, Cognition, Disease Resistance, Excretion, Flight, Localization, Meiosis, Metaphase, Methylation, Pathogenesis, Secretion, Spermatogenesis, Sulfation, Translation, Transport, Virulence

Quite a number of genes have been found to play important roles in Steroid Sulfatase Deficiency Disease, such as CASP3, CYCS, CYP19A1, F2, MID1, PGR, PMEL, POMT1, SLC9A6, STS, SULT1A3, SULT1A4, SULT1E1, SULT2A1, TNF, TP53. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.